Aguirre de Cárcer Daniel, Hernáez Bruno, Rastrojo Alberto, Alcamí Antonio
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain.
PLoS One. 2017 Mar 10;12(3):e0173697. doi: 10.1371/journal.pone.0173697. eCollection 2017.
It is often not possible to demonstrate causality within the context of gut microbiota dysbiosis-linked diseases. Thus, we need a better understanding of the mechanisms whereby an altered host immunophysiology shapes its resident microbiota. In this regard, immune-modulating poxvirus strains and mutants could differentially alter gut mucosal immunity in the context of a natural immune response, providing a controlled natural in vivo setting to deepen our understanding of the immune determinants of microbiome composition. This study represents a proof-of-concept that the use of an existing collection of different immune-modulating poxviruses may represent an innovative tool in gut microbiome research. To this end, 16S rRNA amplicon sequencing and RNAseq transcriptome profiling were employed as proxies for microbiota composition and gut immunophysiological status in the analysis of caecal samples from control mice and mice infected with various poxvirus types. Our results show that different poxvirus species and mutants elicit different shifts in the mice mucosa-associated microbiota and, in some instances, significant concomitant shifts in gut transcriptome profiles, thus providing an initial validation to the proposed model.
在肠道微生物群失调相关疾病的背景下,往往无法证明因果关系。因此,我们需要更好地理解宿主免疫生理学改变塑造其常驻微生物群的机制。在这方面,免疫调节痘病毒株和突变体在自然免疫反应的背景下可能会差异性地改变肠道黏膜免疫,提供一个可控的自然体内环境,以加深我们对微生物组组成的免疫决定因素的理解。这项研究证明了使用现有的不同免疫调节痘病毒集合可能是肠道微生物组研究中的一种创新工具。为此,在分析来自对照小鼠和感染各种痘病毒类型的小鼠的盲肠样本时,采用16S rRNA扩增子测序和RNAseq转录组分析来代表微生物群组成和肠道免疫生理状态。我们的结果表明,不同的痘病毒种类和突变体在小鼠黏膜相关微生物群中引发不同的变化,并且在某些情况下,肠道转录组谱也会发生显著的伴随变化,从而为所提出的模型提供了初步验证。